Co-Diagnostics, Inc. Share Price & Technical Analysis
CODX · $5.07 (+36.66%)
Healthcare / Medical Devices
$5.07
+36.66%
Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. The company also provides…
Price chart
Seasonality
May has 2 positive and 3 negative years (last 5 years shown)
240% return in May, -19% avg return in past 3 year May month.
157% return in 2026, -51% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -53% | -4% | -14% | -12% | 240% | – | – | – | – | – | – | – | 157% |
| 25 | 1% | -34% | -40% | 17% | -29% | 11% | -9% | 30% | 4% | 34% | -18% | -54% | -87% |
| 24 | -4% | -10% | -3% | 3% | -8% | 16% | -6% | 23% | -11% | -4% | -26% | -15% | -45% |
| 23 | 28% | -10% | -50% | -5% | -21% | 2% | 43% | -21% | -14% | 2% | 10% | 15% | -21% |
| 22 | -20% | -19% | 7% | -29% | 14% | 11% | 18% | -49% | -3% | 8% | -14% | -16% | -93% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Downtrend · Overbought
Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. The company also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, malaria, dengue, human papillomavirus, chikungunya, and Zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. Co-Diagnostics, Inc. was incorporated in 2013 and is based in Salt Lake City, Utah.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$6.29M
P/E ratio
—
52W high
$46.50
52W low
$1.26
Volume
97,49,247
Beta
1.26
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Co-Diagnostics, Inc. share price today?
- Co-Diagnostics, Inc. (CODX) last traded around $5.07 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does CODX have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for CODX. Download the app for real-time alerts.
- How can I analyze Co-Diagnostics, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.